{"id":3409,"date":"2024-01-23T11:33:06","date_gmt":"2024-01-23T10:33:06","guid":{"rendered":"https:\/\/www.celltrend.de\/?p=3409"},"modified":"2024-01-23T11:33:06","modified_gmt":"2024-01-23T10:33:06","slug":"celltrend-receives-new-patent","status":"publish","type":"post","link":"https:\/\/www.celltrend.de\/en\/celltrend-receives-new-patent\/","title":{"rendered":"CellTrend receives new patent"},"content":{"rendered":"<p style=\"text-align: center;\">In 2018, James P. Allison and Tasuku Honjo received the Nobel Prize in Medicine for the discovery of a tumor therapy through negative immune regulation. Here, the binding between PD1 (Programmed cell death protein 1) and PD-L1 (Programmed cell death protein 1 ligand) is inhibited. CellTrend has discovered autoantibodies against PD1 and PD-L1 in tumor patients and has been granted a European patent for this discovery.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3407 aligncenter\" src=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2024\/01\/Screenshot-2024-01-23-112735.jpg\" alt=\"\" width=\"638\" height=\"899\" srcset=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2024\/01\/Screenshot-2024-01-23-112735.jpg 638w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2024\/01\/Screenshot-2024-01-23-112735-213x300.jpg 213w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2024\/01\/Screenshot-2024-01-23-112735-106x150.jpg 106w\" sizes=\"auto, (max-width: 638px) 100vw, 638px\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In 2018, James P. Allison and Tasuku Honjo received the Nobel Prize in Medicine for the discovery of a tumor therapy through negative immune regulation. Here, the binding between PD1 (Programmed cell death protein 1) and PD-L1 (Programmed cell death protein 1 ligand) is inhibited. CellTrend has discovered autoantibodies against PD1 and PD-L1 in tumor&hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"yst_prominent_words":[445,246,1150,461,446,614],"class_list":["post-3409","post","type-post","status-publish","format-standard","hentry","category-news-en","category-9","description-off"],"_links":{"self":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/comments?post=3409"}],"version-history":[{"count":2,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3409\/revisions"}],"predecessor-version":[{"id":3411,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3409\/revisions\/3411"}],"wp:attachment":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/media?parent=3409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/categories?post=3409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/tags?post=3409"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/yst_prominent_words?post=3409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}